Discover Asymchem's expertise in using API in drug manufacturing for solid oral dosage forms. Learn about our innovative techniques and commitment to quality in pharmaceutical development.
Leverage our expertise in chemistry, manufacturing, and technology Commercial API drug manufacturing services Second-generation process development for continuous improvement Analytical services Trust our experts and state-of-the-art labs Solubility enhancement solutions Particle size reduction to overcome ...
Trusted in API, intermediates, and custom drugs since 2004. With advanced facilities, we ensure quality, safety, and sustainable pharmaceutical solutions.
由此可见,API粒径对制备工艺也至关重要。Michael Leane 等人5基于不同工艺路线提出生产分类系统(Manufacturing Classification System (MCS))时,把粒径作为API的一项基础理化性质,强调在工艺选择时需要重点关注。例如下图4,提出当选用直接压片工艺时,API的粒径D10一般要...
第一篇发表于2015年,A proposal for a drug product Manufacturing Classification System(MCS) for oral solid dosage forms(DOI: 10.3109/10837450.2014.954728)。第二篇发表于2018年,Manufacturing classification system in the real world: factors influencing manufacturing process choices for filed commercial oral ...
Our active pharmaceutical ingredients (API) development and manufacturing services support your small molecule through early process optimization and scale-up to commercial production.
(APIs), including facilities manufacturing drug substance intermediates used to produce APIs, that are used in FDA-regulated prescription and over-the-counter (OTC) drug products. The purpose of the QMM API Pilot Program is to gain insight from th...
Our teams, backed by 50+ years of experience and a proven track record of excellence, optimize, adapt, and perfect innovative technologies and drug substance development approaches to deliver world-class solutions for pharmaceutical manufacturing. We thrive on the vexing challenges few CDMOs would hav...
Clinical API Manufacturing Reliable manufacturing of drug substances for clinical trials is critical for any pharmaceutical company, but it can be particularly challenging for small and emerging organizations if they lack the in-house expertise, capacity or scale needed as the demand becomes greater in...